GPP

Great Point Partners Portfolio holdings

AUM $154M
1-Year Est. Return 2.36%
This Quarter Est. Return
1 Year Est. Return
-2.36%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$184M
AUM Growth
-$28.2M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
36
New
Increased
Reduced
Closed

Top Buys

1
+$9.55M
2
+$7.79M
3
+$6.41M
4
IMVT icon
Immunovant
IMVT
+$6.41M
5
LEGN icon
Legend Biotech
LEGN
+$4.69M

Top Sells

1
+$8.92M
2
+$7.69M
3
+$6.89M
4
ORKA
Oruka Therapeutics
ORKA
+$4.44M
5
DVAX icon
Dynavax Technologies
DVAX
+$3.43M

Sector Composition

1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
RZLT icon
26
Rezolute
RZLT
$835M
$2.42M 1.28%
833,042
+211,148
CNTA
27
Centessa Pharmaceuticals
CNTA
$3.24B
$2.15M 1.14%
+149,702
VYGR icon
28
Voyager Therapeutics
VYGR
$258M
$2.12M 1.12%
626,275
-200,476
PMN icon
29
ProMIS Neurosciences
PMN
$23.2M
$1.84M 0.97%
2,645,128
UPB
30
Upstream Bio Inc
UPB
$1.18B
$1.84M 0.97%
300,000
PLRX icon
31
Pliant Therapeutics
PLRX
$111M
$1.15M 0.61%
850,000
-205,000
JSPR icon
32
Jasper Therapeutics
JSPR
$66.2M
– –
-322,380
OPTN
33
DELISTED
OptiNose
OPTN
– –
-370,269
SMMT icon
34
Summit Therapeutics
SMMT
$14.4B
– –
0
URGN icon
35
UroGen Pharma
URGN
$878M
– –
-187,843
ORKA
36
Oruka Therapeutics
ORKA
$1.32B
– –
-228,803
1
2